Impact of ABO blood group antigens on residual factor VIII levels and risk of inhibitor development in hemophilia A.
Blood research(2023)
摘要
Unlike what is observed in healthy individuals, blood group did not influence residual FVIII levels across the severity spectrum of HA. Patients in group A had a higher risk of developing inhibitors.
更多查看译文
关键词
Bleeding disorder,Blood group,Factor VIII inhibitors,Hemophilia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要